A+
A-
Yicura BioMed Limited
Writer: | Editor: Cao Zhen | From: HTCZ-SZ | Updated: 2026-11-11
Yicura BioMed Limited is a clinical stage biotechnology group, focusing on research and development of innovative DNA medicines and antibody immunotherapies to fight against cancers, inflammatory and infectious diseases based on its patented PD-1-enhanced DNA Vaccine, Anti-Δ42PD1 Antibody; and Vaccine Delivery platforms.